Potency assays and biomarkers for cell-based advanced therapy medicinal products

Advanced Therapy Medicinal Products (ATMPs) based on somatic cells expanded in vitro, with or without genetic modification, is a rapidly growing area of drug development, even more so following the marketing approval of several such products. ATMPs are produced according to Good Manufacturing Practi...

Cijeli opis

Bibliografski detalji

Glavni autori:	Chiara Capelli, Carolina Cuofano, Chiara Pavoni, Simona Frigerio, Daniela Lisini, Sara Nava, Michele Quaroni, Valentina Colombo, Francesco Galli, Svetlana Bezukladova, Paola Panina-Bordignon, Giuseppe Gaipa, Patrizia Comoli, Giulio Cossu, Gianvito Martino, Andrea Biondi, Martino Introna, Josée Golay
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-06-01
Serija:	Frontiers in Immunology
Teme:	advanced therapy medicinal product (ATMP) potency CAR (chimeric antigen receptor) T cell therapy stem cell tissue regeneration
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186224/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!